Health Care: Drugs

Infinity Pharmaceuticals Inc (INFI: NASDAQ)

$1.54 n/a | n/a%
07/22/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 109.07M 165.00M 0.00 47.11M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 109.07M 165.00M 0.00 47.11M
Selling, General, and Administrative Expenses 37.06M 29.29M 27.92M 27.88M
Research & Development 199.11M 143.63M 99.76M 118.59M
Operating Income before D & A (EBITDA) -127.11M -7.92M -127.68M -99.36M
Depreciation & Amortization 3.21M 12.68M 4.02M 3.30M
Interest Income 0.00 0.00 0.00 559.00K
Other Income - Net 435.00K 339.00K 896.00K 46.75M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -129.88M -20.26M -130.80M -55.35M
Interest Expense 1.37M 9.65M 0.00 1.91M
Pre-Tax Income -131.25M -29.91M -130.80M -57.26M
Income Taxes 335.00K 183.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -128.38M -17.42M -126.78M -53.96M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -128.38M -17.42M -126.78M -53.96M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -128.38M -17.42M -126.78M -53.96M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-128.38M -17.42M -126.78M -53.96M
Preferred Dividends
Net Income Available To Common -128.38M -17.42M -126.78M -53.96M
Basic EPS from Continuing Ops. -2.62 -0.36 -2.64 -1.70
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.62 -0.36 -2.64 -1.70
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.62 -0.36 -2.64 -1.70
Basic Normalized Net Income/Share -2.62 -0.36 -2.64 -1.70
EPS fr Continuing Ops. -2.62 -0.36 -2.64 -1.70
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.62 -0.36 -2.64 -1.70
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.62 -0.36 -2.64 -1.70
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.62 -0.36 -2.64 -1.70
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with INFI

Latest INFI Headlines from TheStreet

More Financial News for INFI

Press Releases for INFI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter